BackCrescent Capital BDC Overview
Crescent Capital BDC Inc

Crescent Capital BDC Target Price

See Crescent Capital BDC's analyst price targets ($13) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.48

Average Target Price

$12.7521.7% upside

4 analysts in the last 4 months

High: $16 | Low: $11

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-17Piper Sandler$1214.5% upsideOpen
2026-08-12Wells FargoFinian O'Shea$115% upsideOpen
2026-05-15Wells FargoFinian O'Shea$1214.5% upsideOpen
2026-05-15Oppenheimer$1652.7% upsideOpen
2026-02-26Raymond JamesRobert Dodd$1433.6% upsideOpen
2025-05-16Wells FargoFinian O'Shea$1543.1% upsideOpen
2024-05-13Wells FargoFinian O'Shea$1871.8% upsideOpen
2024-05-10Raymond JamesRobert Dodd$1981.3% upsideOpen
2022-04-25Wells Fargo$18.576.5% upsideOpen

Crescent Capital BDC (CCAP) FAQ

Crescent Capital BDC's target price stands at $13. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $13 for CCAP implies 21.7% upside versus today's price ($10.48). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Crescent Capital BDC's target price evolved across reporting periods, while the comparison chart places CCAP next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Finance, target price is commonly used to spot outliers. Crescent Capital BDC's reading of $13 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.